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A R T I C L E   I N F O S U M M A R Y 
The aim of the present investigation was to understand the swelling behaviour of 
HPMC and PEO-based matrices and to evaluate the impact of porosity on the 
swelling kinetics. It was noticed that the HPMC has higher swelling rates but both 
undergo diffusion oriented swelling mechanism. It could also the concluded that the 
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INTRODUCTION 
Controlled release dosage forms are developed to 
sustain the delivery of the embedded drug for an 
extended period once administered. This 
phenomenon is usually ensured by using certain 
hydrophilic polymers, for example, hypromellose 
(hydroxypropyl methylcellulose, HPMC) or 
polyethylene oxide (PEO) in which the drug is 
homogenously dispersed. There are various types of 
controlled release formulations, however, 
compressed hydrophilic matrices (CHM) are most 
frequently used controlled release oral dosage forms 
(Maderuelo et al., 2011). Generally, CHM can be easily 
prepared by directly compressing the powder mixture 
of drug containing a swellable hydrophilic polymer 
and other additives to aid the process (Ghori & 
Conway 2016). These CHM have the ability to release 
the drug over a defined period of time, as they do not 
undergo disintegration when delivered to patients. 
Instead, they swell and develop a gel layer on the 
surface of the tablet which controls the liquid 
ingression as well as the diffusion of the drug. 
Swelling is considered to be a fundamental 
characteristic for success and unsatisfactory swelling 
may lead to formulation failure. The liquid imbibition 
into these CHMs is strongly affected by the tablet 
porosity. Commonly, a higher overall porosity leads 
to rapid penetration of liquid molecules in 
comparison to lower overall porosity thus impacting 
on the swelling behaviour (Ghori et al., 2017). 
Therefore, the objective of present study was to 
investigate the impact of porosity on the swelling 
kinetics of HPMC and PEO matrices. 
MATERIALS AND METHODS 
Hypromellose (HPMC, K4M) and polyethylene oxide 
(Polyox, NF60K) were obtained as a kind gift from 
Colorcon®, Dartford, UK.  
HPMC and Polyox samples (500 ± 2.5 mg, 150-250 μm) 
were compressed using a Testometric M500–50 CT 
  https://doi.org/10.5920/bjpharm.2017.16  
Box et al (2017) BJPharm, 2(2), S11-13  S12 
(Testometric Company Ltd., UK) equipped with a 
13.00 mm Atlas Evacuable Tablet Die (Specac® 
Limited, UK). The compacts were fabricated at an 
applied pressure of 150 MPa. After ejection, the tablets 
were stored over silica gel for 24 h to allow for elastic 
recovery before any further investigations. The out-of-
die porosity (ɛ) was calculated using Eq. 1.  (Ghori et 
al., 2014a, 2017). 
 Ɛ  = 1 −
𝑊
𝜌(𝑑/2)²𝜋𝑇
  (Eq. 1) 
where W, T, D, ƿ are weight, thickness diameter and 
true density, respectively. The swelling studies were 
carried out for all the matrices using the gravimetrical 
technique as reported in our previous studies (Ghori 
et al., 2014a; 2014b). The mean weight was determined 
for each matrix tablet and degree of swelling (S) was 
calculated using Eq. (2). The mechanism of swelling 
was evaluated using employing the Vergnaud model 
(Vergnaud 1993). 
𝑆 =  
𝑊𝑠−𝑊𝑖
𝑊𝑖
  × 100  (Eq. 2) 
where Wi and Ws are initial dry and swollen matrix tablet 
weight, respectively, at immersion time (t). 
RESULTS AND DISCUSSION 
Swelling is considered as an essential aspect of 
controlling drug release from hydrophilic matrix 
devices. The swelling study was conducted on the 
matrices, on immersion in liquid the outer surface of 
these polymeric devices and a response was plotted 
(Fig 1a) against time (t). The tactical and visual 
inspection confirmed the appearance of so-called gel 
layer formation. It was apparent the HPMC matrices 
exhibited a higher extent of swelling in comparison to 
PEO (Fig 1a).  The Vergnaud model was employed to 
further understand the swelling mechanism (Fig 1b). 
The swelling kinetics parameters, enlisted in Table 1, 
were well described by this model with high R2 values 
of 0.99. The swelling rate of HPMC based matrices 
(51.14 % min-1) was higher than PEO matrices (39.32 
% min-1). Additionally, based on the resultant 
swelling exponent (n) values (Table 1), both the 
polymer matrices exhibited diffusion controlled 
swelling being slightly higher in HPMC compared to 
PEO. It was interesting to note that this correlates well 
with the porosity. The correlation between porosity 
and swelling rate revealed that, in case of HPMC, 
porosity was lower while the Kw was higher. This 
might be attributed to the higher osmotic stress within 
the compact. However, a higher overall porosity (in 
case of PEO) the might lead to less matrix tortuosity 




Figure 1. Matrix tablet porosity and swelling kinetics 
parameters. 
Table 2. Matrix tablet porosity and swelling kinetics parameters. 
 % min-1 and b porosity (%) 
CONCLUSIONS 
It can be concluded that the HPMC had a higher 
swelling rate in comparison to PEO, under the 
conditions in this study. Moreover, it could also the 
concluded that from the above research finding that 
the porosity has a marked influence on the overall 
swelling behaviour of the polymer matrices. 
Therefore, the present findings can be used in the 
development and tailoring the specific properties of 
controlled release solid dosage forms. 
Parameter HPMC PEO 
Swelling rate (Kw)a 51.14 39.32 
Swelling exponent (n) 0.2831 0.3032 
R2 0.9996 0.9979 
ɛb 0.1607 0.2170 
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